MiMedx Group, Inc. (MDXG) bonds
MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3040% below fair value
$3.18+0.00 (0.00%)
Close on Nov 18, 2026Market cap $464.04MP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
Total debt
$0
$0 due within a year
Net debt
-$120.79M
After $120.79M of cash
Implied interest rate
9.69%
FY2025 interest ÷ average debt
Interest coverage
35.8×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in MiMedx's 10-Q for the period ended Jul 29, 2026
MiMedx's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed. The repayment schedule above comes from the same report.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Drawn |
|---|---|---|
| Citizens Credit Agreement | $10.00M | $0 |
| Hayfin Loan Agreement Term Loan | $300.00M | $17.83M |
See a number that looks wrong?